Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories
Virus-Cell Interactions
[키워드] 3CL
activity
acute respiratory syndrome
addition
anti-CoV drug
antiviral drug
antiviral drugs
biosafety
Biosafety Level 2
Biosafety Level 3
BSL2
BSL3
Cell
cell types
conditions
contagious
coronavirus
CoV
decrease
deleting
development
drug dose
ENCODE
expressing
expression
fluorescent
GFP
glycoprotein
glycoprotein G
host cells
Immunity
Infection
Laboratory
lack
murine
mutant
neutralized
Particle
platform
Protease inhibitor
Protein
Remdesivir
replication of SARS-CoV-2
replicon
reporter
reporters
Research
robust
S gene
SARS-CoV-2
SARS-CoV-2 biology
SARS-CoV-2 research
SARS-CoV-2 virus
Scientific community
serum
spike gene
Support
System
Treatment
Vaccine
variety
vesicular stomatitis virus
viral envelope
viral genome
viral glycoproteins
VSV
[DOI] 10.1128/jvi.01837-21 PMC 바로가기 [Article Type] Virus-Cell Interactions
[DOI] 10.1128/jvi.01837-21 PMC 바로가기 [Article Type] Virus-Cell Interactions